CSIMarket
 
Medifast Inc   (NYSE: MED)
 
Price: $12.6300 $0.09 0.718%
Day's High: $12.65999984741211 Week Perf: 4.04 %
Day's Low: $ 12.38 30 Day Perf: 4.21 %
Volume (M): 53,711 52 Wk High: $ 14.67
Volume (M$): $ 0 52 Wk Avg: $11.57
Open: $12.53 52 Wk Low: $9.22



 Market Capitalization (Millions $) 139
 Shares Outstanding (Millions) 11
 Employees 380
 Revenues (TTM) (Millions $) 345
 Net Income (TTM) (Millions $) -20
 Cash Flow (TTM) (Millions $) -20
 Capital Exp. (TTM) (Millions $) 5

Business Description


Medifast, Inc. is engaged in the production, distribution, and sale of weight loss, weight management, and healthy living products and other consumable health and diet products. The Company primarily operates through its wholly owned subsidiaries, Jason Pharmaceuticals, Inc., Take Shape For Life, LLC, Jason Enterprises, Inc., Medifast Franchise Systems (“MFSI”), Inc., Jason Properties, LLC, Medifast Nutrition, Inc. and Seven Crondall, LLC. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company manufactures a significant portion of its products at its manufacturing facility located in Owings Mills, Maryland.


Over the past 30 years, obesity in the United States has risen dramatically. In 2013, the American Medical Association officially declared obesity a disease and The American Heart Association, the American College of Cardiology, and The Obesity Society recommended that obesity be managed as a chronic disease. Throughout the world, the World Health Organization estimates that approximately 1.9 billion people are overweight. In the United States, over two-thirds of the adult population fall within the overweight or obese categories. According to the Centers for Disease Control and Prevention (“CDC”), over 78 million U.S. adults are obese.

Furthermore, the CDC reported that forty-five states had adult obesity rates of 25% or higher, and twenty-two of these states had obesity rates at 30% or more. Being overweight and/or obese is linked to a multitude of serious comorbidities including heart disease, stroke, Type 2 diabetes, certain types of cancers, arthritis, sleep apnea and depression.

The primary factors contributing to obesity, which are well known are: unhealthy food choices and lack of physical activity. Obesity is not limited to adults; the CDC has reported children and adolescents are also affected. According to the CDC, the prevalence of obesity in children age 6-11 years has doubled and obesity rates have quadrupled in adolescents age 12-19 years in the past 30 years.

The U.S. weight loss market itself is estimated to be a $65 billion per year industry, including consumer spending on diet foods, drinks and low-calorie sweeteners; health clubs and workout videos; medically supervised and commercial weight loss programs; children’s weight loss camps; diet books; appetite suppressants and more. Portion-controlled, meal-replacement weight management programs are continuing to gain popularity, as consumers search for a safe and effective solution that provides balanced nutrition, effective weight loss, and valuable behavior-modification education.




   Company Address: 1501 S. Clinton Street Baltimore 21224 MD
   Company Phone Number: 581-8042   Stock Exchange / Ticker: NYSE MED


Customers Net Income grew by MED's Customers Net Profit Margin grew to

39.87 %

6.63 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BRBR   -2.81%    
HAIN        2.45% 
SMPL        4.76% 
CELH   -7.03%    
DD   -3.93%    
HLF   -0.4%    
• View Complete Report
   



Business Update

Medifast Launches National Marketing Campaign to Promote Holistic Weight Loss Solutions and Partnerships

Published Mon, May 20 2024 1:15 PM UTC

Baltimore-based health and wellness company, Medifast, has recently announced the launch of a multimillion-dollar national marketing campaign in collaboration with LifeMD. The campaign aims to highlight Medifast s new offering, the GLP-1 Lifestyle Program, which provides a holistic approach to medical weight loss tailored to support individuals utilizing GLP-1 medications.Me...

Business Update

Medifast Embarks on Therapeutic Weight Loss Venture with LifeMD in Bid to Transform Business Amidst Challenging Market Conditions

Published Wed, Dec 13 2023 11:00 AM UTC


Medifast, the renowned health and wellness company recognized for its habit-based and coach-guided lifestyle solution, OPTAVIA, has commenced the transformative first phase of its business transformation, with a determined focus on expanding its reach to offer comprehensive health and wellness solutions across the United States.
The Baltimore-based company is makin...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.40
Price to Sales (Expected) -
Price to Book 0.7
PEG (TTM) -

Financial Strength Current
Quick Ratio 4
Working Capital Ratio 4.8
Leverage Ratio (MRQ) 0.28
Total Debt to Equity -
Interest Coverage (TTM) 2.15
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.86 $
Revenues (TTM) 31.32 $
Cash Flow (TTM) -
Cash 15.35 $
Book Value 17.96 $
Dividend (TTM) 0.01 $

Efficiency Current
Revenue per Employee (TTM) 906,987
Net Income per Employee (TTM) -52,689
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) 4.34
Asset Turnover Ratio (TTM) 1.33

Profitability Ratios Current
Gross Margin (MRQ) 68.32 %
Operating Margin (MRQ) -4.35 %
Net Margin (MRQ) -2.8 %
Net Cash Flow Margin (MRQ) -23.46 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield 0.06 %
Pay out Ratio (TTM) -



Medifast Inc's Segments
Optavia segments    100.38 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.